Rituximab may be a safe and effective option for frequently relapsing or steroid-dependent adult-onset nephrotic syndrome, ...

There's a new development in the yearslong international mystery over Havana Syndrome: The U.S. has obtained and has been testing a device that officials believe could be linked to the debilitating ...

The mystery of the so-called Havana Syndrome has stumped experts, intelligence officials and lawmakers for close to a decade. More than 1,000 officials and their family members are thought to have ...

The Pentagon, during the last days of the Biden administration, secretly purchased a device that some investigators believe could be linked to the “Havana Syndrome,” a medical condition that has ...

The Pentagon has tested a device that investigators believe may be linked to the condition commonly referred to as Havana Syndrome, CNN has reported. The Defense Department has been testing the device ...

In a trial, rituximab demonstrated clinical efficacy in reducing proteinuria in patients with FRNS or SDNS. Intravenous rituximab is safe and effective in patients with frequently relapsing nephrotic ...

Long QT syndrome is a leading cause of sudden death in young persons, with a prevalence exceeding 1 in 2000. It is characterized by prolongation of the QT interval, aberrant T-wave morphologic ...

Glomerulonephritis refers to several conditions that affect the structures within the kidneys, whereas nephrotic syndrome refers to a set of symptoms that indicate the kidneys are not working properly ...

Primary nephrotic syndrome in adults is characterized by severe proteinuria and hypoalbuminemia. This was the first clinical trial to test rituximab in adult-onset frequently relapsing nephrotic ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what about patients ...

Osaka, Japan – One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what ...

– If approved, Gazyva could help children and young adults sustain remission, potentially with a reduced need for steroids to manage their disease – – INShore is the first global Phase III study of a ...